Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT.
Saved in:
| Title: | Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT. |
|---|---|
| Authors: | Abou-Ismail MY; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT., Kanack AJ; Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Splinter NP; Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Smock KJ; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT.; Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology®, Salt Lake City, UT; and., Moser KA; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT.; Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology®, Salt Lake City, UT; and., Padmanabhan A; Divisions of Hematopathology, Transfusion Medicine, & Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. |
| Source: | Blood advances [Blood Adv] 2022 Sep 27; Vol. 6 (18), pp. 5327-5329. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35468623 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Abou-Ismail+MY%22">Abou-Ismail MY</searchLink>; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Kanack+AJ%22">Kanack AJ</searchLink>; Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Splinter+NP%22">Splinter NP</searchLink>; Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Smock+KJ%22">Smock KJ</searchLink>; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT.; Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology®, Salt Lake City, UT; and.<br /><searchLink fieldCode="AU" term="%22Moser+KA%22">Moser KA</searchLink>; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT.; Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology®, Salt Lake City, UT; and.<br /><searchLink fieldCode="AU" term="%22Padmanabhan+A%22">Padmanabhan A</searchLink>; Divisions of Hematopathology, Transfusion Medicine, & Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2022 Sep 27; Vol. 6 (18), pp. 5327-5329. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35468623 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2022007753 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5327 Titles: – TitleFull: Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Abou-Ismail MY – PersonEntity: Name: NameFull: Kanack AJ – PersonEntity: Name: NameFull: Splinter NP – PersonEntity: Name: NameFull: Smock KJ – PersonEntity: Name: NameFull: Moser KA – PersonEntity: Name: NameFull: Padmanabhan A IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 09 Text: 2022 Sep 27 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 6 – Type: issue Value: 18 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |
